However, urine contamination with erythrocytes above 250 cells/μl and urinary tract infections yielded false positive results, thus limiting the broad usability of urinary LASP1 levels as TCC-biomarker to cases without urinary tract infection or gross hematuria [104]. This evidence concerns the gene LASP1 and urinary tract infection.